Almac ONE™ Aligns Communications Ensuring Visibility And Accuracy Throughout Phase I Oncology Study

During the planning of a phase I oncology study, a global biotechnology company working with separate vendors for physical supply and IRT faced a common risk: different stakeholders communicating different information to each business unit. Left unmanaged, this kind of data misalignment can lead to inconsistent inventory, kit descriptions, and supply strategies. By unifying physical and digital supply chain operations under one collaborative team, inconsistencies in inventory and kit data were identified and resolved before they could disrupt the study. The result: protocol-specific ancillaries were properly accounted for, future drug ordering issues were eliminated, and the trial proceeded on time and on budget.

Learn how sponsors managing complex, multi-stakeholder supply chains can bridge the gap between physical and digital operations early to prevent costly downstream disruptions and explore how to protect study timelines from day one.